Timely and individualized use of immunosuppression is associated with favourable outcomes in paediatric IgA vasculitis nephritis

Pediatr Nephrol. 2022 Apr;37(4):913-914. doi: 10.1007/s00467-021-05405-0. Epub 2022 Jan 10.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biopsy
  • Child
  • Female
  • Glomerulonephritis* / complications
  • Humans
  • IgA Vasculitis* / diagnosis
  • IgA Vasculitis* / drug therapy
  • Immunosuppression Therapy
  • Male
  • Nephritis*
  • Vasculitis* / complications
  • Vasculitis* / drug therapy